Equecabtagene Autoleucel
IASO Biotherapeutics
['multiple myeloma', 'iaso bio', 'innovent']
dcbn news: innovent and iaso bio updated efficacy and safety clinical data of equecabtagene autoleucel (bcma car-t cell therapy) for multiple myeloma at the 2023 asco annual meeting: rockville, md. and suzhou, ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.